Study guide

Phakomatoses and syndrome-specific surveillance

European Board of Ophthalmology Diploma EBOD

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: EBOD Examination, Applications and Regulations

EBOD Format, Scoring and Revision Planning Eligibility, Applications and the Diploma Online Rules, Technical Preparation and Appeals

2 Chapter 2: Physical Optics, Photometry and Lenses

Light, refraction and total internal reflection Photometry, contrast, colour and adaptation Prisms, decentration and vector combination Vergence, astigmatic lenses and Sturm’s conoid

3 Chapter 3: Instrument Optics, Aberrations and Laser Physics

Cross-cylinder and diagnostic instrument optics Aberrations, duochrome and wavefront analysis Diffraction, polarization, lasers and OCT

4 Chapter 4: Refraction, Accommodation and Spectacle Prescribing

Objective and cycloplegic refraction Subjective refraction and binocular balance Accommodation, presbyopia and vertex distance Spectacle Materials, Measurement and Progressive Lenses

5 Chapter 5: Contact Lenses and Low-Vision Rehabilitation

Contact-lens optics, materials and tear lenses Contact-lens fit and complications Low-vision assessment and magnification Low-vision aids, calculations and ergonomics

6 Chapter 6: Extraocular Anatomy and Motor Physiology

Extraocular muscle anatomy and innervation Eye axes, kinematics and muscle actions Motor laws and orbital pulleys

7 Chapter 7: Binocular Vision and Amblyopia

Binocular vision, stereopsis and the horopter Suppression, correspondence and microtropia Sensory tests and amblyopia treatment

8 Chapter 8: Childhood Assessment and Strabismus Testing

Visual Development, Childhood Testing and Developmental Delay History, corneal reflexes and cover tests Motility patterns, three-step testing and Hess charts

9 Chapter 9: Esotropia, Exotropia and Vertical Deviations

Infantile and accommodative esotropia Exotropia classification and management Vertical Deviations, A–V Patterns and Skew

10 Chapter 10: Dysinnervation, Nystagmus and Muscle Surgery

Duane syndrome, Brown syndrome and restriction Nystagmus patterns and investigation Nystagmus and muscle surgery principles

11 Chapter 11: ROP and Paediatric Ocular Disease

Retinopathy of Prematurity: Screening, Classification and Follow-up Childhood Cataract, Leukocoria and Congenital Glaucoma Childhood Systemic Disease, Infection and Safeguarding

12 Chapter 12: Ocular Surface Anatomy and Infection

Corneal, Conjunctival and Scleral Structure: Examination and Sampling Bacterial keratitis, sampling and treatment Fungal, amoebic and herpetic keratitis Infectious, chlamydial and neonatal conjunctivitis

13 Chapter 13: Allergy, Cicatrisation and Surface Inflammation

Allergic eye disease, trachoma and phlyctenules Cicatrising Conjunctivitis: Mucous Membrane Pemphigoid and SJS/TEN Dry eye, blepharitis and meibomian dysfunction PUK, interstitial keratitis and scleritis

14 Chapter 14: Anterior Segment Dysgenesis and Corneal Dystrophies

Anterior Segment Dysgenesis, Aniridia and Congenital Corneal Opacity IC3D and epithelial or Bowman-layer dystrophies Stromal corneal dystrophies Endothelial corneal dystrophies

15 Chapter 15: Corneal Degeneration, Ectasia and Epithelial Failure

Corneal Degenerations, Pterygium, Band Keratopathy and Dellen Keratoconus and clinical ectasia signs Ectasia imaging, cross-linking and rehabilitation Recurrent Erosion, Neurotrophic Keratopathy and Vitamin A Deficiency

16 Chapter 16: Surface Reconstruction and Keratoplasty

Limbal Stem-Cell Failure, Tarsorrhaphy and Phototherapeutic Keratectomy PK, DALK and endothelial keratoplasty Corneal graft immunity and rejection recognition Graft rejection treatment and postoperative problems

17 Chapter 17: Lens Development, Cataract Assessment and Biometry

Lens Development, Congenital Shape and Ectopia Lentis Lens anatomy and age-related cataract phenotypes Cataract grading, secondary causes and childhood disease Optical and ultrasound biometry

18 Chapter 18: IOL Planning and Phacoemulsification

Keratometry and IOL power formulae Post-refractive biometry, toric alignment and IOL design Phaco fluidics and ultrasound delivery Wounds, OVDs and nucleus techniques

19 Chapter 19: Cataract Anaesthesia and Surgical Complications

Cataract Anaesthesia, Alternative Extraction and Combined Procedures IFIS, capsule rupture and compromised support Postoperative inflammation, haemorrhage and PCO

20 Chapter 20: Corneal and Intraocular Refractive Surgery

Excimer ablation, PRK and LASIK SMILE, surgical selection and complications Phakic IOLs and refractive lens exchange

21 Chapter 21: Presbyopia Procedures and Surface Therapeutics

Presbyopia Surgery, Monovision and Historical Refractive Procedures Surface antimicrobial and anti-inflammatory pharmacology Surface healing, amnion and cenegermin

22 Chapter 22: Aqueous Dynamics, Tonometry and Gonioscopy

Ciliary body and aqueous secretion Outflow and the Goldmann pressure model Tonometry, corneal thickness and biomechanics Gonioscopy optics, landmarks and indentation

23 Chapter 23: Angle, Disc and Visual-Field Assessment

Angle grading and anterior-segment imaging Optic-disc examination and documentation OCT and automated perimetry

24 Chapter 24: Glaucoma Progression, Suspects and Secondary Mechanisms

Field reliability and progression Ocular hypertension, suspects and juvenile glaucoma Lens-related glaucoma, aqueous misdirection and venous pressure

25 Chapter 25: POAG, Angle Closure and Pigmentary Disease

POAG, target pressure and normal-tension disease Angle-closure classification and mechanisms Acute angle closure, iridotomy and lens extraction Pseudoexfoliation and pigmentary glaucoma

26 Chapter 26: Glaucoma Medical, Laser and Surgical Treatment

Neovascular, uveitic and steroid-response glaucoma Glaucoma medicines, SLT and MIGS Trabeculectomy and drainage implants Nonpenetrating surgery, cyclodestruction and postoperative lasers

27 Chapter 27: Retinal Imaging, Diabetes and Vascular Occlusion

Retinal anatomy, examination and multimodal imaging Diabetic microangiopathy and NPDR classification PDR, macular oedema and diabetic trials Retinal vein and artery occlusions

28 Chapter 28: Uncommon Vascular Disease and Myopic Maculopathy

Macroaneurysm, sickle retinopathy and retinal periphlebitis Coats disease and leukocoria assessment MacTel and radiation retinopathy Myopic maculopathy and presumed ocular histoplasmosis

29 Chapter 29: Inherited Retina and Electrophysiology

Retinitis pigmentosa and inherited degeneration Stargardt, Best disease and retinal electrophysiology Cone disorders, stationary night blindness and syndromic retina

30 Chapter 30: AMD, Geographic Atrophy and Pachychoroid

AMD biology and clinical staging Drusen, geographic atrophy and neovascular phenotypes Neovascular AMD trials and treatment CSCR and the pachychoroid spectrum

31 Chapter 31: Retinal Breaks and Detachment Repair

PVD, peripheral degenerations and retinal breaks RRD localization and retinoschisis Detachment mechanisms, pneumatic retinopexy and scleral buckling

32 Chapter 32: Vitrectomy, Macular Surgery and Retinal Trauma

Vitrectomy and intraocular tamponades ERM, macular holes and PVR Retinal trauma, optic-disc pits and choroidal detachment

33 Chapter 33: Uveitis Classification and Non-Infectious Inflammation

SUN classification, grading and uveitis work-up Anterior and intermediate uveitis patterns HLA-B27, sarcoidosis, Behçet disease and VKH Posterior inflammatory patterns and immunomodulation

34 Chapter 34: Infectious Uveitis and Endophthalmitis

Toxoplasmosis and herpetic necrotizing retinitis Ocular syphilis and tuberculosis Immunosuppressed retinitis, toxocariasis and neuroretinitis Endophthalmitis diagnosis and treatment

35 Chapter 35: Optic Neuritis and Ischaemic Optic Neuropathy

Typical optic neuritis and ONTT NMOSD and MOGAD Arteritic optic neuropathy and GCA NAION and ischaemic neuropathy comparison

36 Chapter 36: Papilloedema, IIH and Afferent Localisation

Papilloedema recognition and Frisén grading IIH diagnosis and vision protection Disc drusen and pseudopapilloedema Afferent pathways and chiasmal localization

37 Chapter 37: Congenital, Inherited and Cortical Neuro-Ophthalmology

Cortical vision and higher visual syndromes Neuro-ophthalmic testing and congenital optic discs Inherited, compressive, infiltrative and nutritional optic neuropathies Transient visual loss, headache and neurological emergencies

38 Chapter 38: Central Motor Control and Cranial Nerve Palsies

Central ocular motor control and supranuclear disorders Third- and fourth-nerve palsies Sixth nerve, pontine gaze and cavernous sinus

39 Chapter 39: Myasthenia and Ocular Myopathy

Myasthenic ocular weakness Myasthenia testing and treatment Myopathy, CPEO and Kearns–Sayre syndrome

40 Chapter 40: Pupillary Pathways and Anisocoria

Pupillary pathways and afferent defects Horner syndrome and tonic pupil Light–near dissociation and pupil differentials

41 Chapter 41: Orbit, Thyroid Eye Disease and Ptosis Assessment

Orbital anatomy and thyroid eye disease Orbital infection and idiopathic inflammation Orbital masses, approaches and eye-removal procedures Lid anatomy and ptosis evaluation

42 Chapter 42: Lid Repair and Lacrimal Drainage

Ptosis repair, malposition and eyelid tumours Lash disorders, facial palsy and lid reconstruction Lacrimal drainage and epiphora testing Nasolacrimal obstruction, infection and DCR

43 Chapter 43: Lacrimal Gland Disease, Pathology and Intraocular Tumours

Lacrimal gland inflammation and tumours Ocular histology, specimen handling and special stains Immunophenotyping, molecular pathology and tumour genetics Uveal melanoma and retinoblastoma

44 Chapter 44: Lymphoma, Surface Tumours and Paraneoplastic Disease

Vitreoretinal lymphoma Surface tumours, uveal metastases and benign mimics Paraneoplastic retinopathy, treatment effects and counselling

45 Chapter 45: Ocular Trauma and Vascular Systemic Disease

Trauma terminology and prognostic scoring Chemical injury and surface preservation Open-globe emergency management Vascular, endocrine, pregnancy and renal eye disease

46 Chapter 46: Multisystem Disease and Ophthalmic Pharmacology

Immune, metabolic and multisystem ocular clues Phakomatoses and syndrome-specific surveillance Connective-tissue and metabolic ocular disease Drug delivery and systemic glaucoma effects

47 Chapter 47: Medication Toxicity, Professional Practice and Clinical Stations

Retinal and optic medication toxicity Prevention, consent and professional practice Directed clinical answers and station rehearsal

Phakomatoses and syndrome-specific surveillance

Key Takeaways Explain This Topic AI

NF1 diagnosis includes defined ocular and systemic criteria with age and family context.

NF2-related schwannomatosis, VHL, tuberous sclerosis and Sturge–Weber have different ocular and systemic risks.

Surveillance must follow the syndrome and current programme rather than one identical imaging schedule.

Last updated: October 2026

Neurocutaneous Syndromes (The Phakomatoses)

The phakomatoses (derived from the Greek phakos , meaning "lentil" or "birthmark") encompass a group of congenital neuro-oculo-cutaneous disorders characterized by widespread hamartoma formation involving tissues of ectodermal and mesodermal origin (central nervous system, retina, skin, and visceral organs). Master-level differentiation of these conditions is a consistent testing pillar in the EBOD examination.

  • 1. Neurofibromatosis Type 1 (NF1 / von Recklinghausen Disease)
  • Genetics & Pathophysiology

Inheritance: Autosomal dominant (AD) with 100 % 100\% 100% penetrance but highly variable expressivity; approximately 50 % 50\% 50% of cases arise from de novo spontaneous mutations.

Gene & Locus: NF1 gene located on chromosome 17q11.2 , encoding neurofibromin .

Function: Neurofibromin functions as a GTPase-activating protein (Ras-GAP) that accelerates the hydrolysis of active Ras-GTP into inactive Ras-GDP, negatively regulating the p21-Ras proto-oncogene signaling pathway. Loss of neurofibromin leads to uncontrolled cellular proliferation and tumorogenesis.

Current NF1 Criteria

The 2021 revised criteria require two qualifying features in a person without an affected parent. They include characteristic pigmentary findings, neurofibromas/plexiform neurofibroma, optic-pathway glioma, characteristic bone lesions, two Lisch nodules or two choroidal abnormalities on appropriate imaging, and a heterozygous pathogenic NF1 variant in unaffected tissue. With an affected parent, one qualifying feature can establish the clinical diagnosis. Lisch and choroidal signs are alternatives within one criterion, not two independent points. Pigment-only children require differentiation from Legius syndrome and other conditions. See the international consensus .

  • 2. Neurofibromatosis Type 2 (NF2 / Schwannomatosis-NF2)
  • Genetics & Hallmarks

Inheritance: Autosomal dominant (AD); chromosome 22q12.2 ; NF2 tumor suppressor gene encoding merlin (also known as schwannomin ), a cytoskeletal protein regulating contact-dependent cell growth inhibition.

Hallmark: Bilateral vestibular schwannomas (acoustic neuromas, arising from cranial nerve VIII), presenting in early adulthood with progressive sensorineural hearing loss, tinnitus, and unsteadiness.

Ocular Manifestations (Vital Differentials vs. NF1)

Absence of Lisch Nodules: Lisch nodules are absent in NF2. This is a critical clinical discriminator.

Juvenile Posterior Subcapsular or Cortical Wedge Cataracts: Present in > 60 − 80 % >60-80\% > 60 − 80% of NF2 patients before age 30. Often subtle, appearing as posterior subcapsular or radial cortical opacities.

Combined Hamartoma of the Retina and RPE (CHRRE): A slightly elevated, hyperpigmented, vascularised glial-pigmentary lesion occurring at the optic disc or posterior pole, frequently causing early-onset vitreoretinal traction, epiretinal membrane, and macular distortion.

Epiretinal Membranes (ERMs): Idiopathic ERMs developing in children or young adults should prompt an immediate neuro-ophthalmic workup for NF2.

Cranial Nerve Palsies: Secondary to multiple intracranial schwannomas or meningiomas (e.g., CN III, IV, VI, VII palsy).

  • 3. Tuberous Sclerosis Complex (Bourneville Disease)
  • Genetics & Pathophysiology

Inheritance: Autosomal dominant (AD); high spontaneous mutation rate ( 60 − 70 % 60-70\% 60 − 70% ).

Genes: TSC1 on chromosome 9q34 (encoding hamartin ) and TSC2 on chromosome 16p13.3 (encoding tuberin ). Hamartin and tuberin form an intracellular heterodimer that acts as a GTPase-activating protein for Rheb, exerting a tonic inhibitory effect on the mammalian target of rapamycin complex 1 (mTORC1) . Inactivating mutations cause constitutive mTOR hyperactivation, driving widespread benign hamartoma development.

Ocular Hallmarks

Retinal Astrocytic Hamartomas (50% of patients): Arise from the retinal nerve fiber layer. Two morphologic varieties:

Type 1 (Non-calcified): Flat, smooth, translucent, non-calcified, grey-white circular lesions with feathered margins, most often located in the mid-periphery.

Type 2 (Calcified / Classic Mulberry Lesion): Highly elevated, opaque, multinodular, yellow-white "mulberry-like" lesions located at or adjacent to the optic nerve head. Autofluorescent on fundus autofluorescence (FAF) due to dense calcium deposition. Usually benign and static; rarely produce vitreous hemorrhage or tractional retinal detachment.

Other Ocular Signs: Depigmented iris sectors, iris colobomas, chorioretinal depigmentation ("punched-out" chorioretinal lesions).

Systemic Triad & Organ Involvement

Dermatological: Hypomelanotic macules ( "ash-leaf spots" , ≥ 3 \ge 3 ≥ 3 , illuminated under Wood's UV lamp); facial angiofibromas ( adenoma sebaceum , butterfly distribution over the malar bridge and nasolabial folds); Shagreen patch (connective tissue plaque in lumbosacral region); periungual fibromas ( Koenen tumours ).

Central Nervous System: Cortical tubers, subependymal glial nodules ("candle wax drippings" lining the lateral ventricles), subependymal giant cell astrocytomas (SEGA) near the foramen of Monro (risk of obstructive hydrocephalus; treated with oral mTOR inhibitors such as everolimus ), and infantile spasms (traditionally treated with vigabatrin ).

Visceral Organs: Bilateral renal angiomyolipomas (AMLs; risk of massive retroperitoneal bleeding if > 4 cm >4\text{ cm} > 4 cm ), cardiac rhabdomyomas (present in infancy, frequently undergo spontaneous involution), and pulmonary lymphangioleiomyomatosis (LAM).

  • 4. Von Hippel-Lindau Disease (VHL)
  • Genetics & Molecular Mechanism

Inheritance: Autosomal dominant (AD); chromosome 3p25 ; VHL tumour suppressor gene.

Molecular Biology: The pVHL protein forms a complex that ubiquitinates the alpha subunit of hypoxia-inducible factor (HIF-1 α \alpha α ) , targeting it for rapid proteasomal degradation under normoxic conditions. Inactivating mutations prevent HIF-1 α \alpha α breakdown. Constitutively stabilized HIF-1 α \alpha α translocates to the nucleus, driving massive, unregulated transcription of angiogenic growth factors, including vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF).

Ocular Hallmark: Retinal Capillary Haemangioblastomas (Retinal Angiomatosis)

Occurs in 50 − 70 % 50-70\% 50 − 70% of VHL patients; often the earliest clinical manifestation.

Biomicroscopic Appearance: A discrete, round, elevated, bright orange-red vascular nodule supplied by a markedly dilated, tortuous feeding retinal artery and drained by an engorged, dusky draining vein spanning from the optic disc to the periphery.

Complications: Progressive transudation produces marked lipid exudation (circinate rings, macular star ), subretinal fluid accumulation, tractional or exudative retinal detachment, vitreous hemorrhage, and secondary neovascular glaucoma.

Management: Small peripheral lesions ( < 1.5 mm <1.5\text{ mm} < 1.5 mm ) respond excellently to argon laser photocoagulation applied directly to the tumor and feeding arterioles. Anterior peripheral lesions are treated with transscleral cryotherapy. Vitrectomy is indicated for non-clearing vitreous hemorrhage or tractional detachment. Anti-VEGF agents serve as valuable adjuvants to reduce vascular permeability and exudation.

Systemic Tumors (Mandatory Screening)

CNS Haemangioblastomas: Infratentorial lesions predominantly located in the cerebellum ( 60 − 70 % 60-70\% 60 − 70% ) and spinal cord, presenting with ataxia and obstructive hydrocephalus.

Renal cancer: A major VHL complication. Surveillance includes renal imaging under an age- and organ-specific specialist programme; an identical annual ultrasound/MRI schedule is not appropriate for every patient.

Pheochromocytomas: Occur in the adrenal medulla or sympathetic paraganglia; present with paroxysmal hypertension, palpitations, and headache. Screened via urinary/plasma fractionated metanephrines.

  • 5. Sturge-Weber Syndrome (Encephalotrigeminal Angiomatosis)
  • Genetics & Etiology

Sporadic & Non-inherited: Congenital vascular malformation syndrome arising from a somatic mosaic activating mutation in the GNAQ gene (chromosome 9q21, encoding the G-protein subunit alpha-q, G α q G\alpha_q G α q ​ ).

Clinical Triad

Facial Port-Wine Stain (Naevus Flammeus): A congenital cutaneous capillary-venous malformation present at birth. While it can involve any part of the face, forehead and upper-eyelid distribution raises concern for ocular and leptomeningeal involvement. This follows developmental vascular territory rather than a strict trigeminal V1 dermatome; arrange syndrome-specific assessment rather than assigning a fixed risk from the stain alone.

Ocular Manifestations:

Glaucoma (50-60%): Develops ipsilateral to the port-wine stain. Exhibits a bimodal onset:

Infantile onset (60%): Secondary to congenital anterior chamber angle dysgenesis and trabeculodysgenesis.

Juvenile / Adult onset (40%): Secondary to elevated episcleral venous pressure (EVP) driven by arteriovenous shunting within episcleral hemangiomas.

Surgical Warning: Filtration surgery carries an exceptionally high risk of ciliochoroidal effusion, severe intraoperative hypotony, and expulsive suprachoroidal haemorrhage due to the sudden decompression of an engorged uveal bed.

Diffuse Choroidal Haemangioma (50%): A diffuse, cavernous vascular malformation of the choroid, giving the fundus an intensely fiery red, saturated appearance compared to the normal fellow eye, classically termed the "tomato-ketchup fundus" . B-scan ultrasound demonstrates diffuse, smooth choroidal thickening with high, regular internal acoustic reflectivity. Complications include progressive hyperopic shift and bullous exudative retinal detachment.

Neurological Manifestations: Ipsilateral leptomeningeal angiomatosis (pial vascular malformation) leading to cerebral cortical ischemia, progressive neuronal loss, and cerebral hemiatrophy. Classically displays gyriform "tram-track" cortical calcifications on skull radiographs or non-contrast brain CT. Patients suffer from medically refractory focal motor seizures, contralateral hemiparesis, and cognitive delay.